Von Hippel Lindau Syndrome

Overview

5 out of 5 (1 Reviews)

Credits

1.25

Post Assessment Questions

11

Expiration Date

31 Dec 2023

Last Reviewed

1 Jan 2021

Estimated Time To Finish

75 Minutes

Stay up to date on the latest medical knowledge

Start This Activity
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Von Hippel-Lindau (VHL) syndrome is an autosomal dominant disease affecting several organ systems. The disease is characterized by the growth of cysts and/or tumors. Tumors can either be benign or malignant. The characteristic tumor type in VHL is the hemangioblastoma, which is a benign tumor comprised of newly formed blood vessels. Hemangioblastomas in the central nervous system and retina can cause complications, including ataxia and vision loss. Renal cell carcinoma (RCC) and pancreatic neuroendocrine tumors are also seen in patients with VHL. This activity reviews the evaluation and management of Von Hippel-Lindau syndrome and underscores the interprofessional team's role in improving care for the patients with this condition.

Activity Image

Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Summarize the typical presentation of a patient with Von Hippel-Lindau syndrome.
  • Describe the pathophysiology of Von Hippel-Lindau syndrome.
  • Outline the typical imaging findings associated with Von-Hippel Lindau lesions.
  • Explain the importance of improving care coordination amongst the interprofessional team to enhance the management and delivery of care for patients with Von Hippel-Lindau syndrome.

Author(s) / Contributors Disclosure of Conflicts of Interest

Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Continuing Education Accreditation Information


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.

Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity is reported to the following Maintenance of Certification (MOC) boards:
American Board of Internal Medicine
  • Internal Medicine
  • Nephrology
American Board of Ophthalmology
  • Retina/Vitreous
American Board of Pathology
  • Molecular Genetic Pathology
American Board of Pediatrics
  • General Pediatrics
  • Pediatric Nephrology
  • Pediatric Neurology

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearls and ETSU reserve the right to cancel any course due to unforeseen circumstances. StatPearls and ETSU will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and ETSU are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives, and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation survey. 
  7. Obtain a certificate.

StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

  • If you need help with the system or have a question about content, please contact support@statpearls.com, or call 727-289-9796.
  • If you have a question about the ETSU CME providership, please contact wolfes1@etsu.edu.

 

Media Usage Rights

The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity.  All copyrights are reserved.

    Reviews

    Dr Haresh D. on 3/30/2022

    Unlimited Physician CME

    Stay up to date on the latest medical knowledge with 6491 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7208 hours of CME.

    Learn About Lifetime CME

    6 Month Unlimited Physician CME

    Access to all the Unlimited Physician CME activities in all specialties.

    $249 per half year per user

    1 Year Unlimited Physician CME

    Access to all the Unlimited Physician CME activities in all specialties.

    $349 per 1 year per user